Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stichting Wetenschappelijk Onderzoek het Oogziekenhuis (SWOO) is the dedicated research foundation of the Rotterdam Eye Hospital, a leading center for ophthalmology in Europe. The foundation facilitates and conducts high-quality clinical research aimed at improving the diagnosis and treatment of vision-threatening eye diseases. Its work spans various sub-specialties, including retina, glaucoma, and cornea, often involving international clinical trials for new pharmacological agents and surgical devices. SWOO serves as a bridge between academic innovation and clinical application, ensuring that research findings are directly translated into enhanced patient care. The organization collaborates extensively with academic institutions like Erasmus MC and global pharmaceutical partners to advance the field of ophthalmology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stichting Wetenschappelijk Onderzoek het Oogziekenhuis.